Re: Inhibition of De Novo Lipogenesis Targets Androgen Receptor Signaling in Castration-Resistant Prostate Cancer

被引：0
|
作者：
Atala, Anthony
机构：
来源：
JOURNAL OF UROLOGY | 2019年 / 202卷 / 02期
关键词：
D O I：
10.1097/01.JU.0000559616.03626.0d
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：214 / 214
页数：1
相关论文
共 50 条
  • [31] Androgen biosynthesis in castration-resistant prostate cancer
    Penning, Trevor M.
    ENDOCRINE-RELATED CANCER, 2014, 21 (04) : T67 - T78
  • [32] Evolution of Castration-Resistant Prostate Cancer in ctDNA during Sequential Androgen Receptor Pathway Inhibition
    Annala, Matti
    Taavitsainen, Sinja
    Khalaf, Daniel J.
    Vandekerkhove, Gillian
    Beja, Kevin
    Sipola, Joonatan
    Warner, Evan W.
    Herberts, Cameron
    Wong, Amanda
    Fu, Simon
    Finch, Daygen L.
    Oja, Conrad D.
    Vergidis, Joanna
    Zulfiqar, Muhammad
    Eigl, Bernhard J.
    Kollmansberger, Christian K.
    Nykter, Matti
    Gleave, Martin E.
    Chi, Kim N.
    Wyatt, Alexander W.
    CLINICAL CANCER RESEARCH, 2021, 27 (16) : 4610 - 4623
  • [33] Effect of Androgen Receptor Suppression Using Dominant Negative Inhibition on Castration-Resistant Prostate Cancer
    Zeithaml, Brian J.
    Titus, Mark
    Haack, Karin
    Cockrell, Adam
    Ponguta, Angela
    Wilson, Elizabeth
    Mohler, James
    Kafri, Tal
    MOLECULAR THERAPY, 2006, 13 : S365 - S365
  • [34] Alternative polyadenylation of androgen receptor variants in castration-resistant prostate cancer
    Van Etten, Jamie L.
    Nyquist, Michael
    Li, Yingming
    LaRue, Rebecca
    Ho, Yeung
    Yang, Rendong
    Voytas, Daniel F.
    Henzler, Christine
    Dehm, Scott M.
    CANCER RESEARCH, 2018, 78 (13)
  • [35] Androgen Receptor Directed Therapies in Castration-Resistant Metastatic Prostate Cancer
    Won Kim
    Charles J Ryan
    Current Treatment Options in Oncology, 2012, 13 : 189 - 200
  • [36] Plasma Androgen Receptor and Docetaxel for Metastatic Castration-resistant Prostate Cancer
    Conteduca, Vincenza
    Jayaram, Anuradha
    Romero-Laorden, Nuria
    Wetterskog, Daniel
    Salvi, Samanta
    Gurioli, Giorgia
    Scarpi, Emanuela
    Castro, Elena
    Marin-Aguilera, Mercedes
    Lolli, Cristian
    Schepisi, Giuseppe
    Maugeri, Antonio
    Wingate, Anna
    Farolfi, Alberto
    Casadio, Valentina
    Medina, Ana
    Puente, Javier
    Mendez Vidal, Ma Jose
    Morales-Barrera, Rafael
    Villa-Guzman, Jose C.
    Hernando, Susana
    Rodriguez-Vida, Alejo
    Gonzalez-del-Alba, Aranzazu
    Mellado, Begona
    Gonzalez-Billalabeitia, Enrique
    Olmos, David
    Attard, Gerhardt
    De Giorgi, Ugo
    EUROPEAN UROLOGY, 2019, 75 (03) : 368 - 373
  • [37] Androgen Receptor Inhibitors in Patients With Nonmetastatic Castration-Resistant Prostate Cancer
    George, Daniel J.
    Morgans, Alicia K.
    Constantinovici, Niculae
    Khan, Nasreen
    Khan, Javeed
    Chen, Guifang
    Hlebec, Vlasta
    Shore, Neal D.
    JAMA NETWORK OPEN, 2024, 7 (08)
  • [38] Spironolactone: A selective androgen receptor modulator in castration-resistant prostate cancer
    Barthelemy, Philippe
    Erdmann, Eva
    Duclos, Brigitte
    Bergerat, Jean Pierre
    Kurtz, Jean-Emmanuel
    Ceraline, Jocelyn
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [39] Targeting the androgen receptor: improving outcomes for castration-resistant prostate cancer
    Scher, HI
    Buchanan, G
    Gerald, W
    Butler, LM
    Tilley, WD
    ENDOCRINE-RELATED CANCER, 2004, 11 (03) : 459 - 476
  • [40] Recent Discoveries in the Androgen Receptor Pathway in Castration-Resistant Prostate Cancer
    Obinata, Daisuke
    Lawrence, Mitchell G.
    Takayama, Kenichi
    Choo, Nicholas
    Risbridger, Gail P.
    Takahashi, Satoru
    Inoue, Satoshi
    FRONTIERS IN ONCOLOGY, 2020, 10
12345